Ubwoko / lymphoma / umurwayi / umuntu mukuru-hodgkin-kuvura-pdq

Abakuze Hodgkin Lymphoma Kuvura (®) –Umurwayi

Amakuru Rusange Yerekeye Abakuze Hodgkin Lymphoma

INGINGO Z'INGENZI

• Lymphoma ikuze ya Hodgkin ni indwara ingirabuzimafatizo (kanseri) ziba muri sisitemu ya lymph.

• Ubwoko bubiri bwingenzi bwa lymphoma ya Hodgkin ni: classique na nodular lymphocyte-yiganje.

• Imyaka, kuba umugabo, kwandura Epstein-Barr, hamwe namateka yumuryango wa lymphoma ya Hodgkin birashobora kongera ibyago byo kurwara lymphoma ikuze.

• Ibimenyetso bya lymphoma ikuze ya Hodgkin harimo kubyimba lymph node, kubyimba, kubira ibyuya nijoro, guta ibiro, n'umunaniro.

• Ibizamini bisuzuma sisitemu ya lymph nibindi bice byumubiri bikoreshwa mugufasha gusuzuma no gutera lymphoma ikuze ya Hodgkin.

• Ibintu bimwe bigira ingaruka kubitekerezo (amahirwe yo gukira) hamwe nuburyo bwo kuvura.

Lymphoma ikuze ya Hodgkin ni indwara ingirabuzimafatizo (kanseri) ziba muri sisitemu ya lymph.

Lymphoma ikuze Hodgkin ni ubwoko bwa kanseri ikura muri sisitemu ya lymph. Sisitemu ya lymph igizwe na sisitemu yumubiri. Ifasha kurinda umubiri kwandura n'indwara.

Sisitemu ya lymph igizwe nibi bikurikira:

• Lymph: Amazi adafite ibara, amazi atembera mumitsi ya lymph kandi atwara lymphocytes T na B. Lymphocytes ni ubwoko bwamaraso yera.

• Imiyoboro ya Lymph: Urusobe rw'imiyoboro yoroheje ikusanya lymph mu bice bitandukanye by'umubiri ikayisubiza mu maraso.

• Indimu ya Lymph: Inzira ntoya, imeze nk'ibishyimbo iyungurura lymph kandi ikabika selile yera ifasha kurwanya indwara n'indwara. Indimu ya Lymph iboneka murusobe rwimitsi ya lymph umubiri wose. Amatsinda ya lymph node aboneka muri mediastinum (agace kari hagati yibihaha), ijosi, munsi yintoki, inda, igitereko, nigituba. Lymphoma ya Hodgkin ikunze kuboneka mumyanya ya lymph hejuru ya diaphragm kandi akenshi muri lymph node muri mediastinum.

• Ururenda: Urugingo rukora lymphocytes, rukabika uturemangingo tw'amaraso atukura na lymphocytes, muyungurura amaraso, no gusenya uturemangingo twa kera. Ururenda ruri ku ruhande rw'ibumoso rw'inda hafi y'igifu.

• Thymus: Urugingo T lymphocytes T ikura ikagwira. Tymus iri mu gituza inyuma yigituza.

• Amagufa yo mu magufa: Uturemangingo tworoshye, twinshi hagati yamagufwa amwe, nk'amagufwa yo mu kibuno ndetse n'igituza. Uturemangingo twamaraso yera, selile zitukura, na platine bikozwe mumagufwa.

• Tonsil: Imbaga ebyiri ntoya ya lymph tissue inyuma yumuhogo. Hano hari toni imwe kuri buri ruhande rw'umuhogo. Abakuze Hodgkin lymphoma ntibakunze kuboneka muri toni.

Anatomy ya sisitemu ya lymph, yerekana imiyoboro ya lymph ningingo zirimo lymph node, toni, tymus, spleen, hamwe namagufa. Lymph (fluid fluid) na lymphocytes zinyura mumitsi ya lymph no mumitsi ya lymphcytes aho lymphocytes zangiza ibintu byangiza. Lymph yinjira mumaraso binyuze mumitsi minini hafi yumutima.

Lymph tissue iboneka no mubindi bice byumubiri, nko gutondeka inzira yigifu, bronchus, nuruhu.

Hariho ubwoko bubiri rusange bwa lymphoma: Lymphoma ya Hodgkin na lymphoma itari Hodgkin. Iyi ncamake yerekeye kuvura lymphoma ikuze ya Hodgkin, harimo no gutwita.

Kumakuru yerekeye lymphoma ya Hodgkin mubana, lymphoma ikuze itari Hodgkin, cyangwa lymphoma mubantu barwaye syndrome de immunodeficiency (sida), reba incamake ya ikurikira:

• Abakuze Kuvura Lymphoma Ntabwo Hodgkin

• Umwana Hodgkin Lymphoma

• Kuvura Lymphoma bijyanye na sida

Ubwoko bubiri bwingenzi bwa lymphoma ya Hodgkin ni: classique na nodular lymphocyte-yiganje.

Lymphoma nyinshi ya Hodgkin nubwoko bwa kera. Iyo icyitegererezo cya lymph node tissue kirebye munsi ya microscope, hashobora kuboneka selile kanseri ya lymphoma ya Hodgkin, yitwa selile Reed-Sternberg. Ubwoko bwa kera bwacitsemo ibice bine bikurikira:

• Nodular sclerose Hodgkin lymphoma.

• Imvange ya selile Hodgkin lymphoma.

• Lymphocyte depletion Hodgkin lymphoma.

• Lymphocyte ikungahaye cyane ya Hodgkin lymphoma.

Lymphocyte ya Nodular yiganjemo lymphoma ya Hodgkin ntisanzwe kandi ikunda gukura gahoro gahoro kurusha lymphoma ya Hodgkin. Lymphocyte ya Nodular yiganjemo lymphoma ya Hodgkin ikunze kugaragara nk'imitsi yabyimbye mu ijosi, mu gituza, mu kuboko, cyangwa mu kibero. Abantu benshi nta bindi bimenyetso cyangwa ibimenyetso bya kanseri bisuzumwa. Ubuvuzi akenshi butandukanye na lymphoma ya kera ya Hodgkin.

Imyaka, kuba umugabo, kwandura Epstein-Barr, hamwe namateka yumuryango wa lymphoma ya Hodgkin birashobora kongera ibyago byo kurwara lymphoma ikuze.

Ikintu cyose cyongera ibyago byo kwandura byitwa impanuka. Kugira ibintu bishobora guteza ibyago ntibisobanura ko uzarwara kanseri; kutagira ibyago bishobora gusobanura ko utazarwara kanseri. Vugana na muganga wawe niba utekereza ko ushobora guhura n'akaga. Impamvu zishobora gutera lymphoma ikuze ya Hodgkin harimo ibi bikurikira:

• Imyaka. Lymphoma ya Hodgkin ikunze kugaragara cyane mubukure (imyaka 20-39) no mubukure (imyaka 65 nayirenga).

• Kuba umugabo. Ibyago bya lymphoma ikuze ya Hodgkin iri hejuru cyane kubagabo kuruta kubagore.

• Indwara ya Epstein-Barr yashize. Kugira kwandura virusi ya Epstein-Barr mu myaka y'ubwangavu cyangwa mu bwana bwana byongera ibyago byo kurwara lymphoma ya Hodgkin.

• Amateka yumuryango ya lymphoma ya Hodgkin. Kugira umubyeyi, umuvandimwe, cyangwa mushiki wawe hamwe na lymphoma ya Hodgkin byongera ibyago byo kurwara lymphoma ya Hodgkin.

Ibimenyetso bya lymphoma ikuze ya Hodgkin harimo kubyimba lymph node, kubyimba, kubira ibyuya nijoro, guta ibiro, n'umunaniro.

Ibi bimenyetso nibindi bimenyetso bishobora guterwa na lymphoma ikuze ya Hodgkin cyangwa nibindi bihe. Menyesha umuganga wawe niba ufite ibimenyetso bikurikira bikurikira bitagenda:

• Kubabara, kubyimba lymph node mu ijosi, munsi yintoki, cyangwa mugituba.

• Umuriro nta mpamvu izwi.

• Kuruha ibyuya nijoro.

• Kugabanuka ibiro nta mpamvu izwi mumezi 6 ashize.

• Uruhu ruteye, cyane nyuma yo kwiyuhagira cyangwa kunywa inzoga.

• Kumva unaniwe cyane.

Umuriro nta mpamvu izwi, guta ibiro nta mpamvu izwi, hamwe no kubira ibyuya nijoro byitwa ibimenyetso B. Ibimenyetso B ni igice cyingenzi cyo gutera lymphoma ya Hodgkin no gusobanukirwa amahirwe yumurwayi yo gukira.

Ibizamini bisuzuma sisitemu ya lymph nibindi bice byumubiri bikoreshwa mugufasha gusuzuma no gutera lymphoma ikuze ya Hodgkin.

Ibisubizo by'ibizamini hamwe nuburyo bukurikira nabyo bifasha gufata ibyemezo bijyanye no kuvura.

Ibi bizamini birashobora kubamo:

• Ikizamini cyumubiri namateka yubuzima: Ikizamini cyumubiri kugirango ugenzure ibimenyetso rusange byubuzima, harimo no gusuzuma ibimenyetso byindwara, nkibibyimba cyangwa ikindi kintu cyose gisa nkidasanzwe. Hazafatwa kandi amateka yubuzima bwumurwayi, harimo umuriro, ibyuya nijoro, no kugabanya ibiro, indwara zashize hamwe nubuvuzi.

• Kubara amaraso yuzuye (CBC): Uburyo bwo gukuramo urugero rwamaraso no gusuzuma ibi bikurikira:

• Umubare w'uturemangingo tw'amaraso atukura, selile yera, na platine.

• Ingano ya hemoglobine (proteyine itwara ogisijeni) mu ngirangingo z'amaraso atukura.

• Igice cy'icyitegererezo kigizwe na selile zitukura.

Kubara amaraso yuzuye (CBC). Amaraso akusanywa no kwinjiza inshinge mumitsi no kwemerera amaraso gutembera mumiyoboro. Icyitegererezo cyamaraso cyoherezwa muri laboratoire hanyuma selile zitukura, selile yera, na platine zirabaze. CBC ikoreshwa mugupima, gusuzuma, no gukurikirana ibintu byinshi bitandukanye.

• Ubushakashatsi bwa chimie yamaraso: Uburyo bwo gusuzuma urugero rwamaraso kugirango bapime urugero rwibintu bimwe na bimwe bisohoka mumaraso ningingo nuduce twumubiri. Umubare udasanzwe (uri hejuru cyangwa uri munsi yubusanzwe) ibintu bishobora kuba ikimenyetso cyindwara.

• Ikizamini cya LDH: Uburyo bwo gusuzuma urugero rwamaraso kugirango bapime urugero rwa dehydrogenase (LDH). Ubwiyongere bwa LDH mumaraso bushobora kuba ikimenyetso cyangirika kwinyama, lymphoma, cyangwa izindi ndwara.

• Ikizamini cya Hepatite B na hepatite C: Uburyo bwo gusuzuma urugero rwamaraso kugirango bapime ingano ya virusi yihariye ya virusi ya hepatite B na / cyangwa antibodi hamwe nubunini bwa virusi ya hepatite C. Izi antigene cyangwa antibodies bita marikeri. Ibimenyetso bitandukanye cyangwa guhuza ibimenyetso bikoreshwa kugirango hamenyekane niba umurwayi afite hepatite B cyangwa C, yaba yaranduye mbere cyangwa inkingo, cyangwa ashobora kwandura. Kumenya niba umurwayi afite hepatite B cyangwa C birashobora gufasha kuvura.

• Kwipimisha virusi itera sida: Ikizamini cyo gupima urugero rwa virusi ya immunodeficiency ya virusi itera SIDA mu cyitegererezo cy'amaraso. Antibodies zikorwa numubiri iyo zatewe nibintu byamahanga. Urwego rwo hejuru rwa antibodiyite ya sida rushobora gusobanura ko umubiri wanduye virusi itera sida. Kumenya niba umurwayi afite virusi itera sida birashobora gufasha kuvura.

• Igipimo cyo kugabanuka: Uburyo bwo gukuramo urugero rwamaraso no kugenzurwa nigipimo umuvuduko wamaraso atukura atura munsi yigitereko. Igipimo cyimitsi ni igipimo cyerekana uko umuriro mwinshi mu mubiri. Ikigereranyo kirenze igipimo gisanzwe gishobora kuba ikimenyetso cya lymphoma cyangwa ikindi kibazo. Ikitwa kandi igipimo cya erythrocyte, igipimo cya sed, cyangwa ESR.

• PET-CT scan: Uburyo bukomatanya amashusho kuva positron yoherejwe na tomografiya (PET) scan hamwe na tomografi yabazwe (CT) scan. Gusikana PET na CT bikorwa icyarimwe kumashini imwe. Amashusho yo muri scan zombi arahujwe kugirango akore ishusho irambuye kuruta ikizamini cyonyine. Isuzuma rya PET-CT rishobora gukoreshwa mu gufasha gusuzuma indwara nka kanseri, kumenya icyiciro, kuvura gahunda, cyangwa kumenya uburyo ubuvuzi bukora neza.

• CT scan (CAT scan): Uburyo bukora urukurikirane rwamashusho arambuye yibice biri mumubiri, nk'ijosi, igituza, inda, pelvis, na lymph node, byafashwe muburyo butandukanye. Amashusho yakozwe na mudasobwa ihujwe na mashini ya x-ray. Irangi rishobora guterwa mumitsi cyangwa kumirwa kugirango bifashe ingingo cyangwa ingirangingo kugaragara neza. Ubu buryo kandi bwitwa computing tomografiya, tomografiya ya mudasobwa, cyangwa mudasobwa ya axial tomografiya. Niba PET-CT scan idashoboka, CT scan yonyine irashobora gukorwa.

• PET scan (positron emission tomografi scan): PET scan nuburyo bwo gushakisha ingirabuzimafatizo mbi mumubiri. Umubare muto wa glucose ikora radio (isukari) yatewe mumitsi. PET scaneri izenguruka umubiri kandi ikora ishusho yerekana aho glucose ikoreshwa mumubiri. Utugingo ngengabuzima twibibyimba twerekana neza cyane ku ishusho kuko zikora cyane kandi zifata glucose nyinshi kuruta selile zisanzwe.

• Lymph node biopsy: Gukuraho ibintu byose cyangwa igice cya lymph node. Inzobere mu bijyanye n’indwara ireba ingirangingo ziri munsi ya microscope kugira ngo ishakishe kanseri yitwa Reed-Sternberg. Ingirabuzimafatizo-Sternberg zisanzwe muri lymphoma ya Hodgkin.

Akagari ka Sternberg. Ingirabuzimafatizo-Sternberg ni nini, lymphocytes zidasanzwe zishobora kuba zifite nucleus zirenze imwe. Izi selile ziboneka muri lymphoma ya Hodgkin.

Bumwe mu bwoko bukurikira bwa biopsies burashobora gukorwa:

• Biopsy idasanzwe: Gukuraho lymph node yose.

• Biopsy incisional: Gukuraho igice cya lymph node.

• Core biopsy: Gukuraho tissue muri lymph node ukoresheje urushinge runini.

Ibindi bice byumubiri, nkumwijima, ibihaha, amagufwa, igufwa ryubwonko, nubwonko, birashobora kandi gukuramo urugero rwimitsi kandi bigasuzumwa numuhanga mubya patologue ibimenyetso bya kanseri.

Ikizamini gikurikira kirashobora gukorwa kuri tissue yakuweho:

• Immunophenotyping: Ikizamini cya laboratoire ikoresha antibodies kugirango hamenyekane kanseri ya kanseri ukurikije ubwoko bwa antigene cyangwa ibimenyetso hejuru ya selile. Iki kizamini gikoreshwa mugufasha gusuzuma ubwoko bwihariye bwa lymphoma.

Ku bagore batwite bafite lymphoma ya Hodgkin, hakoreshwa ibizamini byo gufata amashusho birinda umwana utaravuka ingaruka z’imishwarara. Muri byo harimo:

• MRI . Ubu buryo bwitwa kandi magnetic magnetic resonance imaging (NMRI). Ku bagore batwite, irangi ritandukanye ntirikoreshwa mugihe gikwiye.

• Ikizamini cya Ultrasound: Uburyo bukoreshwa mu majwi menshi y’amajwi (ultrasound) asohoka mu ngingo cyangwa mu ngingo imbere hanyuma agasubiramo. Ijwi ryerekana ishusho yumubiri wumubiri witwa sonogram.

Ibintu bimwe bigira ingaruka kubitekerezo (amahirwe yo gukira) hamwe nuburyo bwo kuvura.

Kumenyekanisha (amahirwe yo gukira) hamwe nuburyo bwo kuvura biterwa nibi bikurikira:

• Ibimenyetso byumurwayi nibimenyetso, harimo niba bafite ibimenyetso B (umuriro nta mpamvu izwi, kugabanuka ibiro nta mpamvu izwi, cyangwa ibyuya byijoro).

• Icyiciro cya kanseri (ingano y'ibibyimba bya kanseri kandi niba kanseri yarakwirakwiriye mu nda cyangwa itsinda rirenga rimwe rya lymph node).

• Ubwoko bwa lymphoma ya Hodgkin.

• Ibisubizo by'amaraso.

• Imyaka yumurwayi, igitsina, nubuzima rusange.

• Niba kanseri imaze gusuzumwa, ikomeza kwiyongera mugihe cyo kuvura, cyangwa yagarutse nyuma yo kuvurwa.

Kuri Hodgkin lymphoma mugihe utwite, uburyo bwo kuvura nabwo buterwa na:

• Ibyifuzo byumurwayi.

• Imyaka yumwana utaravuka.

Lymphoma ikuze Hodgkin irashobora gukira iyo ibonetse ikavurwa hakiri kare.

Ibyiciro by'abakuze Hodgkin Lymphoma

INGINGO Z'INGENZI

• Nyuma yo gupimwa lymphoma ya Hodgkin ikuze, hakorwa ibizamini kugirango hamenyekane niba kanseri ya kanseri yakwirakwiriye muri sisitemu ya lymph cyangwa mu bindi bice by'umubiri.

• HARI uburyo butatu kanseri ikwirakwira mu mubiri.

• ATH ibyiciro bikurikira bikoreshwa kumuntu mukuru Hodgkin lymphoma:

• AStage I.

• AStage II

• Igice cya III

• Igice cya IV

• AAdult Hodgkin lymphoma irashobora guhurizwa hamwe kugirango ivurwe kuburyo bukurikira:

• Nibyiza

• AEarly Ntabwo ari byiza

• Yongeyeho

Nyuma yo gupimwa lymphoma ya Hodgkin ikuze, hakorwa ibizamini kugirango hamenyekane niba kanseri ya kanseri yakwirakwiriye muri sisitemu ya lymph cyangwa mu bindi bice by'umubiri.

Inzira ikoreshwa mu kumenya niba kanseri yarakwirakwiriye muri sisitemu ya lymph cyangwa mu bindi bice byumubiri byitwa guterana. Amakuru yakusanyirijwe mubikorwa byateguwe agena icyiciro cyindwara. Ni ngombwa kumenya icyiciro cyo gutegura imiti. Ibisubizo by'ibizamini n'inzira zakozwe mu gusuzuma no gutera lymphoma ya Hodgkin ikoreshwa mu gufasha gufata ibyemezo bijyanye no kuvura.

Hariho uburyo butatu kanseri ikwirakwira mu mubiri.

Kanseri irashobora gukwirakwira binyuze mu ngingo, sisitemu ya lymph, n'amaraso:

• Tissue. Kanseri ikwirakwira aho yatangiriye ikurira mu turere twegereye.

• Sisitemu ya Lymph. Kanseri ikwirakwira aho yatangiriye yinjira muri sisitemu ya lymph. Kanseri inyura mu mitsi ya lymph igana mu bindi bice by'umubiri.

• Amaraso. Kanseri ikwirakwira aho yatangiriye yinjira mu maraso. Kanseri inyura mu mitsi y'amaraso igana mu bindi bice by'umubiri.

Ibyiciro bikurikira bikoreshwa kumuntu mukuru Hodgkin lymphoma:

Icyiciro I.

Icyiciro cya I lymphoma ikuze. Kanseri iboneka muri lymph node imwe cyangwa nyinshi mumatsinda ya lymph node, cyangwa, gake, kanseri iboneka mumpeta ya Waldeyer, thymus, cyangwa spleen. Mu cyiciro cya IE (kiterekanwa), kanseri yakwirakwiriye mu gace kamwe ka sisitemu ya lymph.

Icyiciro cya I mukuru Hodgkin lymphoma igabanijwemo ibyiciro I na IE.

• Mu cyiciro cya I, kanseri iboneka muri hamwe mu buryo bukurikira muri sisitemu ya lymph:

• Imwe cyangwa nyinshi ya lymph node mumatsinda ya lymph node.

• Impeta ya Waldeyer.

• Tymus.

• Intanga.

• Mu cyiciro cya IE, kanseri iboneka ahantu hamwe hanze ya sisitemu ya lymph.

Icyiciro cya II

Icyiciro cya II abakuze Lymphoma ya Hodgkin igabanijwemo ibyiciro II na IIE.

• Mu cyiciro cya II, kanseri iboneka mu matsinda abiri cyangwa menshi ya lymph node iri hejuru ya diafragma cyangwa munsi ya diafragma.

Icyiciro cya II lymphoma ikuze. Kanseri iboneka mu matsinda abiri cyangwa menshi ya lymph node iri hejuru ya diafragma cyangwa munsi ya diafragma.

Mu cyiciro cya IIE, kanseri yakwirakwiriye mu itsinda rya lymph node kugera mu gace kegereye kari hanze ya sisitemu ya lymph. Kanseri irashobora gukwirakwira mu yandi matsinda ya lymph node kuruhande rumwe rwa diafragma.

Icyiciro cya IIE lymphoma ikuze. Kanseri yakwirakwiriye mu itsinda rya lymph node kugera ahantu hegereye hanze ya sisitemu ya lymph. Kanseri irashobora gukwirakwira mu yandi matsinda ya lymph node kuruhande rumwe rwa diafragma.

Mu cyiciro cya II, ijambo indwara nini ryerekeza ku mubyimba munini. Ingano yibibyimba byitwa indwara nini iratandukanye bitewe n'ubwoko bwa lymphoma.

Icyiciro cya III

Icyiciro cya III lymphoma ikuze. Kanseri iboneka mu matsinda ya lymph node haba hejuru no munsi ya diafragma; cyangwa mumatsinda ya lymph node hejuru ya diaphragm no mumutwe.

Mu cyiciro cya III umuntu mukuru Hodgkin lymphoma, kanseri iboneka:

• mu matsinda ya lymph node haba hejuru no munsi ya diafragma; cyangwa

• muri lymph node hejuru ya diaphragm no mumutwe.

Icyiciro cya IV

Icyiciro cya IV lymphoma ikuze. Kanseri (a) yakwirakwiriye mu ngingo imwe cyangwa nyinshi hanze ya sisitemu ya lymph; cyangwa (b) iboneka mu matsinda abiri cyangwa menshi ya lymph node iri hejuru ya diafragma cyangwa munsi ya diafragma no mu rugingo rumwe ruri hanze ya lymph kandi rutari hafi ya lymph node; cyangwa (c) iboneka mumatsinda ya lymph node hejuru ya diafragma no munsi ya diafragma no mubice byose biri hanze ya sisitemu ya lymph; cyangwa (d) iboneka mu mwijima, mu magufa, ahantu henshi mu bihaha, cyangwa mu bwonko bwa cerebrospinal (CSF). Kanseri ntiyakwirakwiriye mu mwijima, mu magufa, mu bihaha, cyangwa CSF kuva hafi ya lymph node.

Mu cyiciro cya IV umuntu mukuru Hodgkin lymphoma, kanseri:

• yakwirakwiriye mu ngingo imwe cyangwa nyinshi hanze ya lymph sisitemu; cyangwa

• iboneka mu matsinda abiri cyangwa menshi ya lymph node iri hejuru ya diafragma cyangwa munsi ya diafragma no mu rugingo rumwe ruri hanze ya lymph kandi rutari hafi ya lymph node; cyangwa

• iboneka mumatsinda ya lymph node haba hejuru no munsi ya diafragma no mubice byose biri hanze ya sisitemu ya lymph; cyangwa

• iboneka mu mwijima, mu magufa, ahantu henshi mu bihaha, cyangwa mu bwonko bwa cerebrospinal (CSF). Kanseri ntiyakwirakwiriye mu mwijima, mu magufa, mu bihaha, cyangwa CSF kuva hafi ya lymph node.

Lymphoma ikuze Hodgkin irashobora guhurizwa hamwe kugirango ivurwe kuburyo bukurikira:

Birakunzwe

Lymphoma ya Hodgkin ikuze hakiri kare ni icyiciro cya I cyangwa icyiciro cya II, nta mpanuka zishobora kongera amahirwe yuko kanseri izagaruka imaze kuvurwa.

Ntibyoroshye

Indwara ya Lymphoma ya Hodgkin hakiri kare ni icyiciro cya I cyangwa icyiciro cya II hamwe na kimwe cyangwa byinshi mu bintu bikurikira bishobora guteza amahirwe kanseri yagaruka nyuma yo kuvurwa:

• Kugira ikibyimba mu gituza kinini kuruta 1/3 cy'ubugari bw'igituza cyangwa byibuze santimetero 10.

• Kugira kanseri mu rugingo rutari lymph node.

• Kugira umuvuduko mwinshi (murugero rwamaraso, selile zitukura zitura munsi yigitereko cyihuta kuruta ibisanzwe).

• Kugira lymph node eshatu cyangwa nyinshi hamwe na kanseri.

• Kugira ibimenyetso B (umuriro nta mpamvu izwi, kugabanuka ibiro nta mpamvu izwi, cyangwa ibyuya byijoro).

Yateye imbere

Lymphoma yateye imbere ni icyiciro cya III cyangwa icyiciro cya IV. Lymphoma nziza ya Hodgkin isobanura ko umurwayi afite 0–3 byimpamvu zikurikira. Lymphoma ya Hodgkin yateye imbere bivuze ko umurwayi afite 4 cyangwa byinshi mubintu bishobora gutera ingaruka hepfo. Ibintu byinshi bishobora gutera umurwayi, birashoboka cyane ko kanseri izagaruka imaze kuvurwa:

• Kugira amaraso make ya alubumu (protein) (munsi ya 4).

• Kugira urwego ruto rwa hemoglobine (munsi ya 10.5).

• Kuba umugabo.

• Kuba ufite imyaka 45 cyangwa irenga.

• Kugira icyiciro cya IV.

• Kugira umubare munini wamaraso yera (15,000 cyangwa arenga).

• Kugira lymphocyte nkeya (munsi ya 600 cyangwa munsi ya 8% yumubare wamaraso yera).

Gusubiramo Abakuze Hodgkin Lymphoma

Indwara ya lymphoma ikuze ya Hodgkin ni kanseri yagarutse (garuka) imaze kuvurwa. Kanseri irashobora kugaruka muri sisitemu ya lymph cyangwa mubindi bice byumubiri.

Incamake yo kuvura

INGINGO Z'INGENZI

• Hariho uburyo butandukanye bwo kuvura abarwayi bafite lymphoma ikuze ya Hodgkin.

• Abarwayi bafite lymphoma ya Hodgkin bagomba gutegurwa nubuvuzi bwitsinda ryabatanga ubuvuzi bafite ubuhanga bwo kuvura lymphoma.

• Umuti wa lymphoma ukuze Hodgkin urashobora gutera ingaruka.

• Ubwoko bune bwo kuvura busanzwe bukoreshwa:

• Chimoterapi

• Imiti ivura imirasire

• Ubuvuzi bugamije

• Immunotherapy

• Ku barwayi batwite bafite lymphoma ya Hodgkin, uburyo bwo kuvura burimo:

• Gutegereza neza

• Ubuvuzi bwa Steroid

• Ubwoko bushya bwo kuvura burimo kugeragezwa mubigeragezo byamavuriro.

• Chimoterapi hamwe no guhinduranya ingirangingo

• Abarwayi barashobora kwifuza gutekereza kubijyanye no kwipimisha kwa muganga.

• Abarwayi barashobora kwipimisha kwa muganga mbere, mugihe, cyangwa nyuma yo gutangira kuvura kanseri.

• Ibizamini byo gukurikirana birashobora gukenerwa.

Hariho uburyo butandukanye bwo kuvura abarwayi bafite lymphoma ikuze ya Hodgkin.

Ubwoko butandukanye bwo kuvura burahari kubarwayi bafite lymphoma ya Hodgkin ikuze. Bumwe mu buvuzi busanzwe (ubu bukoreshwa mu kuvura), kandi bumwe burimo kugeragezwa mu mavuriro. Ikigeragezo kivura ni ubushakashatsi bwakozwe bugamije gufasha kunoza imiti igezweho cyangwa kubona amakuru ku buvuzi bushya ku barwayi ba kanseri. Iyo ibizamini byo kwa muganga byerekana ko ubuvuzi bushya buruta ubuvuzi busanzwe, ubuvuzi bushya bushobora kuba ubuvuzi busanzwe. Abarwayi barashobora kwifuza gutekereza kubijyanye no kwipimisha kwa muganga. Ibigeragezo bimwe na bimwe bivura abarwayi batatangiye kwivuza.

Ku bagore batwite bafite lymphoma ya Hodgkin, ubuvuzi bwatoranijwe neza kugirango burinde umwana utaravuka. Ibyemezo byo kuvura bishingiye ku byifuzo bya nyina, icyiciro cya lymphoma ya Hodgkin, n'imyaka y'uruhinja rutaravuka. Gahunda yo kuvura irashobora guhinduka nkibimenyetso nibimenyetso, kanseri, no gutwita. Guhitamo uburyo bukwiye bwo kuvura kanseri nicyemezo kirimo cyane cyane umurwayi, umuryango, hamwe nitsinda ryita kubuzima.

Abarwayi bafite lymphoma ya Hodgkin bagomba gutegurwa nubuvuzi bwitsinda ryabatanga ubuvuzi bafite ubuhanga bwo kuvura lymphoma.

Ubuvuzi buzakurikiranwa n’umuganga wa oncologue, umuganga winzobere mu kuvura kanseri. Umuganga wa oncologue arashobora kukwohereza kubandi bashinzwe ubuzima bafite uburambe nubuhanga mu kuvura lymphoma ikuze ya Hodgkin kandi bazobereye mu bice bimwe na bimwe by’ubuvuzi. Aba bashobora kuba barimo inzobere zikurikira:

• Imirasire ya oncologue.

• Inzobere mu gusubiza mu buzima busanzwe.

• Hematologue.

• Abandi bahanga ba oncology.

Umuti wa lymphoma ukuze Hodgkin urashobora gutera ingaruka.

Kumakuru yingaruka zitangira mugihe cyo kuvura kanseri, reba urupapuro rwuruhande rwacu.

Ingaruka ziterwa no kuvura kanseri zitangira nyuma yo kuvurwa zikomeza amezi cyangwa imyaka byitwa ingaruka zitinze. Umuti hamwe na chimiotherapie hamwe na / cyangwa imiti ivura lymphoma ya Hodgkin irashobora kongera ibyago bya kanseri ya kabiri nibindi bibazo byubuzima mumezi menshi cyangwa imyaka nyuma yo kuvurwa. Izi ngaruka zitinze ziterwa n'ubwoko bwo kwivuza n'imyaka umurwayi amaze kuvurwa, kandi bishobora kuba bikubiyemo ibi bikurikira:

• Kanseri ya kabiri.

• Indwara ya myelogenous leukemia na lymphoma itari Hodgkin.

• Ibibyimba bikomeye, nka mesothelioma na kanseri y'ibihaha, amabere, tiroyide, amagufwa, inyama zoroshye, igifu, esofagusi, colon, rectum, cervix, n'umutwe n'ijosi.

• Kutabyara.

• Hypothyroidism (imisemburo ya tiroyide nkeya mumaraso).

• Indwara z'umutima, nk'indwara y'umutima.

• Ibibazo by'ibihaha, nk'ikibazo cyo guhumeka.

• Indwara ya necrosis yo mu magufa (urupfu rw'utugingo ngengabuzima twatewe no kubura amaraso).

• Indwara ikabije.

• Umunaniro udashira.

Gukurikiranwa buri gihe n'abaganga b'inzobere mu gushakisha no kuvura ingaruka zitinze ni ngombwa ku buzima bw'igihe kirekire bw'abarwayi bavuwe na lymphoma ya Hodgkin.

Ubwoko bune bwo kuvura busanzwe bukoreshwa:

Chimoterapi

Chimoterapi ni umuti wa kanseri ukoresha imiti imwe cyangwa myinshi kugirango uhagarike imikurire ya kanseri, haba mu kwica selile cyangwa kubabuza gutandukana. Kuvura kanseri ukoresheje imiti irenga imwe ya chimiotherapie bita chimiotherapie. Iyo chimiotherapie ifashwe numunwa cyangwa igaterwa mumitsi cyangwa imitsi, imiti yinjira mumaraso kandi irashobora kugera kanseri ya kanseri mumubiri (chimiotherapie sisitemu). Iyo chimiotherapie ishyizwe mumazi yubwonko, urugingo, cyangwa umwobo wumubiri nkinda, imiti yibasira kanseri ya kanseri muri utwo turere (chimiotherapie yo mukarere).

Uburyo chimiotherapie itangwa biterwa nubwoko nicyiciro cya kanseri ivurwa. Sisitemu yo kuvura ya chimiotherapie ikoreshwa mukuvura lymphoma ikuze ya Hodgkin.

Iyo umugore utwite avuwe na chimiotherapie ya lymphoma ya Hodgkin, ntibishoboka kurinda umwana utaravuka guhura na chimiotherapie. Uburyo bumwe na bumwe bwa chimiotherapie bushobora gutera ubumuga iyo butanzwe mugihembwe cyambere. Vinblastine ni imiti igabanya ubukana itajyanye n'ubumuga bwo kuvuka iyo itanzwe mu gihembwe cya kabiri cyangwa icya gatatu cyo gutwita.

Reba Ibiyobyabwenge Byemewe kuri Lymphoma ya Hodgkin kubindi bisobanuro.

Imiti ivura imirasire

Imishwarara ivura ni imiti ikoresha kanseri ikoresha ingufu nyinshi za x-imirasire cyangwa ubundi bwoko bwimirasire yica kanseri cyangwa ikabuza gukura. Imiti ivura hanze ikoresha imashini hanze yumubiri kugirango yohereze imirasire yerekeza kumubiri hamwe na kanseri. Rimwe na rimwe, imirasire yumubiri yose ihabwa umubiri wose mbere yo guterwa ingirangingo.

Ubuvuzi bwa proton beam imirasire burimo kwigwa kuvura abarwayi b'abakobwa bakiri bato kugirango bagabanye ibyago byo kurwara kanseri y'ibere. Imiti ivura imirasire ya proton ikoresha imigezi ya proton (uduce duto dufite charge nziza) kugirango yice selile. Ubu buryo bwo kuvura burashobora kugabanya urugero rwimirasire yangiza ingirabuzimafatizo hafi yikibyimba nkumutima cyangwa ibere.

Imiti ivura hanze ikoreshwa mu kuvura lymphoma ikuze ya Hodgkin kandi irashobora no gukoreshwa nk'ubuvuzi bwa palliative kugirango igabanye ibimenyetso kandi imibereho myiza.

Ku mugore utwite ufite lymphoma ya Hodgkin, kuvura imirasire bigomba gusubikwa kugeza nyuma yo kubyara, niba bishoboka, kugira ngo hatabaho ingaruka zose ziterwa n'imirase ku mwana uri mu nda. Niba hakenewe kuvurwa ako kanya, umugore arashobora guhitamo gukomeza gutwita no guhabwa imiti ivura imirasire. Inkinzo ya gurşide ikoreshwa mugupfuka inda yumugore utwite kugirango ifashe kurinda umwana utaravuka imirase ishoboka.

Ubuvuzi bugamije

Ubuvuzi bugamije ni uburyo bwo kuvura bukoresha ibiyobyabwenge cyangwa ibindi bintu byibasira kanseri. Ubuvuzi bugamije bushobora guteza ingaruka nke kuri selile zisanzwe kuruta chimiotherapie cyangwa imiti ivura imirasire.

Ubuvuzi bwa antibody ya Monoclonal ni ubwoko bwubuvuzi bugamije gukoreshwa mu kuvura lymphoma ya Hodgkin.

• Ubuvuzi bwa antibody ya Monoclonal nubuvuzi bukoresha antibodies zakozwe muri laboratoire, uhereye mubwoko bumwe bwimikorere yumubiri. Iyi antibodies irashobora kumenya ibintu biri muri kanseri ya kanseri cyangwa ibintu bisanzwe bishobora gufasha kanseri gukura. Antibodiyite ifata ibintu kandi ikica selile ya kanseri, ikabuza gukura kwayo, cyangwa ikabuza gukwirakwira. Antibodiyite za Monoclonal zitangwa no gushiramo. Bashobora gukoreshwa bonyine cyangwa gutwara ibiyobyabwenge, uburozi, cyangwa ibikoresho bya radio bikoresha kanseri ya kanseri.

Brentuximab na rituximab ni antibodiyite za monoclonal zikoreshwa mu kuvura lymphoma ya Hodgkin.

Reba Ibiyobyabwenge Byemewe kuri Lymphoma ya Hodgkin kubindi bisobanuro.

Immunotherapy

Immunotherapy nubuvuzi bukoresha sisitemu yumubiri yumurwayi kurwanya kanseri. Ibintu bikozwe numubiri cyangwa bikozwe muri laboratoire bikoreshwa mukuzamura, kuyobora, cyangwa kugarura umubiri kamere irinda kanseri. Ubu bwoko bwo kuvura kanseri nabwo bwitwa biotherapy cyangwa biologique therapy.

Immune checkpoint inhibitor therapy ni ubwoko bwikingira.

• Immune checkpoint inhibitor therapy: PD-1 ni poroteyine hejuru ya selile T ifasha kugenzura ubudahangarwa bw'umubiri. Iyo PD-1 ifatanye nindi poroteyine yitwa PDL-1 kuri selile ya kanseri, ihagarika selile T kwica kanseri. Inzitizi za PD-1 zifatanije na PDL-1 kandi zemerera selile T kwica selile.

Nivolumab na pembrolizumab ni ubwoko bwimiti igabanya ubukana ikoreshwa mu kuvura lymphoma ya Hodgkin yagarutse (garuka).

Immune igenzura. Intungamubiri za poroteyine, nka PD-L1 ku ngirabuzimafatizo na PD-1 kuri selile T, zifasha kugenzura ibisubizo by’ubudahangarwa. Guhambira PD-L1 na PD-1 bituma selile T itica selile yibibyimba mumubiri (panne ibumoso). Guhagarika guhuza PD-L1 na PD-1 hamwe na inhibitor igenzura (anti-PD-L1 cyangwa anti-PD-1) ituma selile T yica selile yibibyimba (panne iburyo).

Reba Ibiyobyabwenge Byemewe kuri Lymphoma ya Hodgkin kubindi bisobanuro.

Ku barwayi batwite bafite lymphoma ya Hodgkin, uburyo bwo kuvura burimo:

Gutegereza neza

Gutegereza witonze ni ugukurikiranira hafi imiterere yumurwayi utabanje kwivuza keretse ibimenyetso cyangwa ibimenyetso bigaragara cyangwa bihindutse. Imirimo irashobora guterwa mugihe umwana utaravuka afite ibyumweru 32 kugeza 36 kugirango nyina atangire kwivuza.

Ubuvuzi bwa Steroid

Steroide ni imisemburo ikorwa muburyo busanzwe mumubiri na glande ya adrenal no mubice byimyororokere. Ubwoko bumwebumwe bwa steroid bukorerwa muri laboratoire. Imiti imwe n'imwe ya steroid yabonetse ifasha chimiotherapie gukora neza no gufasha guhagarika imikurire ya selile. Iyo kubyara hakiri kare, steroid irashobora kandi gufasha ibihaha byumwana utaravuka gukura vuba kurenza ibisanzwe. Ibi biha abana bavutse kare amahirwe menshi yo kubaho.

Reba Ibiyobyabwenge Byemewe kuri Lymphoma ya Hodgkin kubindi bisobanuro.

Ubwoko bushya bwo kuvura burimo kugeragezwa mubigeragezo byamavuriro.

Iki gice cyincamake gisobanura imiti irimo kwigwa mubigeragezo byamavuriro. Ntishobora kuvuga ubuvuzi bushya burimo kwigwa. Amakuru yerekeye ibizamini byamavuriro araboneka kurubuga rwa NCI.

Chimoterapi hamwe no guhinduranya ingirangingo

Umubare munini wa chimiotherapie utangwa kugirango wice selile. Ingirabuzimafatizo nzima, harimo na selile zikora amaraso, nazo zirasenywa no kuvura kanseri. Gutera ingirabuzimafatizo ni uburyo bwo gusimbuza ingirabuzimafatizo. Ingirabuzimafatizo (selile zidakuze) zivanwa mumaraso cyangwa igufwa ryumurwayi cyangwa umuterankunga hanyuma bikonjeshwa bikabikwa. Umurwayi amaze kurangiza imiti ya chimiotherapie hamwe nimirasire yimirasire, ingirabuzimafatizo zabitswe zashwanyagujwe hanyuma zisubizwa umurwayi binyuze mu gushiramo. Izi ngirabuzimafatizo zongeye gukoreshwa zikura (kandi zigarura) ingirangingo z'amaraso z'umubiri.

Abarwayi barashobora kwifuza gutekereza kubijyanye no kwipimisha kwa muganga.

Ku barwayi bamwe, kwitabira ikizamini cyamavuriro birashobora kuba uburyo bwiza bwo kuvura. Ibigeragezo bivura biri mubikorwa byubushakashatsi bwa kanseri. Igeragezwa rya Clinical rikorwa kugirango hamenyekane niba imiti mishya ya kanseri itekanye kandi ifite akamaro cyangwa nziza kuruta ubuvuzi busanzwe.

Benshi mubuvuzi busanzwe bwa kanseri bushingiye kubigeragezo byambere byubuvuzi. Abarwayi bitabiriye kwipimisha barashobora kuvurwa bisanzwe cyangwa kuba mubambere bahawe imiti mishya.

Abarwayi bitabira ibizamini byo kwa muganga nabo bafasha kunoza uburyo kanseri izavurwa mugihe kizaza. Nubwo ibigeragezo bivura bitaganisha ku buvuzi bushya, akenshi basubiza ibibazo byingenzi kandi bigafasha gutera imbere ubushakashatsi.

Abarwayi barashobora kwipimisha kwa muganga mbere, mugihe, cyangwa nyuma yo gutangira kuvura kanseri.

Igeragezwa rimwe na rimwe ririmo abarwayi bataravurwa. Ibindi bigeragezo bipima abarwayi bafite kanseri itameze neza. Hariho kandi ibizamini byo kwa muganga bipima uburyo bushya bwo guhagarika kanseri kongera kugaruka (kugaruka) cyangwa kugabanya ingaruka zo kuvura kanseri.

Igeragezwa rya Clinical ririmo kubera mu bice byinshi by'igihugu. Amakuru yerekeye ibizamini byamavuriro ashyigikiwe na NCI urashobora kubisanga kurubuga rwa NCI. Ibizamini bya Clinical bishyigikiwe nandi mashyirahamwe murashobora kubisanga kurubuga rwa ClinicalTrials.gov.

Ibizamini byo gukurikirana birashobora gukenerwa.

Bimwe mubizamini byakozwe mugupima kanseri cyangwa kumenya icyiciro cya kanseri birashobora gusubirwamo. Ibizamini bimwe bizasubirwamo kugirango harebwe uburyo ubuvuzi bukora neza. Ibyemezo bijyanye no gukomeza, guhindura, cyangwa guhagarika ubuvuzi birashobora gushingira kubisubizo byibi bizamini.

Bimwe mubizamini bizakomeza gukorwa buri gihe nyuma yubuvuzi burangiye. Ibisubizo by'ibi bizamini birashobora kwerekana niba ubuzima bwawe bwarahindutse cyangwa niba kanseri yarongeye (garuka). Ibi bizamini rimwe na rimwe byitwa gukurikirana-ibizamini cyangwa kugenzura.

Amahitamo yo kuvura hakiri kare Hodgkin Lymphoma

Kuvura lymphoma ya kera ya Hodgkin nziza kubantu bakuze irashobora kuba ikubiyemo ibi bikurikira:

• Ubuvuzi bwa chimiotherapie.

• Gukomatanya chimiotherapie hamwe nubuvuzi bwimirasire mubice byumubiri hamwe na kanseri.

• Imishwarara yimirasire yonyine kubarwayi badashobora kuvurwa hamwe na chimiotherapie.

Kumakuru yubuvuzi buvuzwe haruguru, reba igice cyo kuvura cyo kuvura.

Koresha ubushakashatsi bwamavuriro kugirango ushakishe NCI ifashwa na kanseri ivura abarwayi. Urashobora gushakisha ibigeragezo ukurikije ubwoko bwa kanseri, imyaka yumurwayi, n’aho ibizamini bikorerwa. Amakuru rusange yerekeye ibizamini byamavuriro nayo arahari.

Amahitamo yo Kuvura hakiri kare ya Hodgkin Lymphoma

Kuvura lymphoma ya kera ya Hodgkin idakwiye kubantu bakuru irashobora kubamo ibi bikurikira:

• Gukomatanya chimiotherapie hamwe nubuvuzi bwimirasire mubice byumubiri hamwe na kanseri.

• Ubuvuzi bwa chimiotherapie.

• Igeragezwa rya clinique yubuvuzi bugamije hamwe na antibody ya monoclonal (brentuximab) cyangwa immunotherapie hamwe nubuvuzi bwikingira.

Kumakuru yubuvuzi buvuzwe haruguru, reba igice cyo kuvura cyo kuvura.

Koresha ubushakashatsi bwamavuriro kugirango ushakishe NCI ifashwa na kanseri ivura abarwayi. Urashobora gushakisha ibigeragezo ukurikije ubwoko bwa kanseri, imyaka yumurwayi, n’aho ibizamini bikorerwa. Amakuru rusange yerekeye ibizamini byamavuriro nayo arahari.

Amahitamo yo kuvura ya Lymphoma ya kera ya Hodgkin

Kuvura lymphoma ya kera ya Hodgkin mu bantu bakuru irashobora kuba ikubiyemo ibi bikurikira:

• Ubuvuzi bwa chimiotherapie.

Kumakuru yubuvuzi buvuzwe haruguru, reba igice cyo kuvura cyo kuvura.

Koresha ubushakashatsi bwamavuriro kugirango ushakishe NCI ifashwa na kanseri ivura abarwayi. Urashobora gushakisha ibigeragezo ukurikije ubwoko bwa kanseri, imyaka yumurwayi, n’aho ibizamini bikorerwa. Amakuru rusange yerekeye ibizamini byamavuriro nayo arahari.

Amahitamo yo kuvura Lymphoma ya Hodgkin isanzwe

Kuvura lymphoma ya Hodgkin isanzwe ikuze kubantu bakuru irashobora kubamo ibi bikurikira:

• Ubuvuzi bugamije hamwe na antibody ya monoclonal (brentuximab).

• Imiti ya chimiotherapie ikurikirwa na chimiotherapie ikabije hamwe no guhinduranya ingirangingo. Imishwarara irashobora gutangwa mugihe kanseri igumye

nyuma yo kuvurwa. Ubuvuzi bugamije (brentuximab) bushobora gutangwa nyuma yo guterwa ingirangingo.

• Immunotherapy hamwe na inhibitor ya immunite (nivolumab cyangwa pembrolizumab).

• Ubuvuzi bwa chimiotherapie.

• Gukomatanya imiti hamwe nubuvuzi bwimirasire mubice byumubiri hamwe na kanseri kubarwayi barengeje imyaka 60.

• Imishwarara ivura hamwe na chimiotherapie cyangwa idafite, kubarwayi bafite kanseri yagarutse gusa mumitsi.

• Chimoterapi nka palliative therapy kugirango igabanye ibimenyetso kandi imibereho myiza.

Kumakuru yubuvuzi buvuzwe haruguru, reba igice cyo kuvura cyo kuvura.

Koresha ubushakashatsi bwamavuriro kugirango ushakishe NCI ifashwa na kanseri ivura abarwayi. Urashobora gushakisha ibigeragezo ukurikije ubwoko bwa kanseri, imyaka yumurwayi, n’aho ibizamini bikorerwa. Amakuru rusange yerekeye ibizamini byamavuriro nayo arahari.

Amahitamo yo kuvura Lymphocyte Nodular - Lymphoma yiganjemo Hodgkin

Kuvura lymphocyte nodular - yiganjemo lymphoma ya Hodgkin ku bantu bakuru irashobora kuba ikubiyemo ibi bikurikira:

• Ubuvuzi bwimirasire mubice byumubiri hamwe na kanseri, kubarwayi barwaye lymphocyte yo mu cyiciro cya mbere - yiganjemo lymphoma ya Hodgkin.

• Chimiotherapie, kubarwayi bafite lymphocyte yo mu rwego rwo hejuru - yiganjemo lymphoma ya Hodgkin.

• Ubuvuzi bugamije hamwe na antibody ya monoclonal (rituximab).

Kumakuru yubuvuzi buvuzwe haruguru, reba igice cyo kuvura cyo kuvura.

Amahitamo yo kuvura Lymphoma ya Hodgkin Mugihe cyo Gutwita

Muri iki gice

• Lymphoma ya Hodgkin Mugihembwe cya mbere cyo Gutwita

• Lymphoma ya Hodgkin Mugihembwe cya kabiri cyangwa icya gatatu cyo Gutwita

Kumakuru yerekeye imiti yavuzwe hepfo, reba igice cyo kuvura.

Lymphoma ya Hodgkin Mugihembwe cya mbere cyo Gutwita

Iyo lymphoma ya Hodgkin isuzumwe mu gihembwe cya mbere cyo gutwita, ntibisobanura ko byanze bikunze umugore azagirwa inama yo kurangiza gutwita. Ubuvuzi bwa buri mugore buzaterwa nicyiciro cya lymphoma, uko ikura vuba, nibyifuzo bye. Kuvura lymphoma ya Hodgkin mugihembwe cya mbere cyo gutwita bishobora kuba bikubiyemo ibi bikurikira:

• Gutegereza witonze iyo kanseri iri hejuru ya diafragma kandi ikura buhoro. Imirimo irashobora guterwa kandi umwana akabyara hakiri kare kugirango nyina atangire kwivuza.

• Imishwarara ivura iyo kanseri iri hejuru ya diafragma. Inkinzo ya sisitemu ikoreshwa mukurinda umwana utaravuka imirase ishoboka.

• Chimiotherapie ukoresheje imiti imwe cyangwa myinshi.

Lymphoma ya Hodgkin Mugihembwe cya kabiri cyangwa icya gatatu cyo Gutwita

Iyo lymphoma ya Hodgkin isuzumwe mugice cya kabiri cyo gutwita, abagore benshi barashobora gutinza kwivuza kugeza umwana avutse. Kuvura lymphoma ya Hodgkin mugihembwe cya kabiri cyangwa icya gatatu cyo gutwita bishobora kuba bikubiyemo ibi bikurikira:

• Gutegereza witonze, ufite gahunda yo kubyara imirimo mugihe umwana utaravuka afite ibyumweru 32 kugeza 36.

• Imishwarara ivura ibibazo byo guhumeka biterwa nikibyimba kinini mu gatuza.

• Gukomatanya chimiotherapie ukoresheje imiti imwe cyangwa nyinshi.

• Ubuvuzi bwa Steroid.

Kugira ngo umenye byinshi kubyerekeye abakuze Hodgkin Lymphoma

Ushaka amakuru menshi yikigo cyigihugu cya kanseri kubyerekeye lymphoma ikuze ya Hodgkin, reba ibi bikurikira:

• Urupapuro rwa Lymphoma

• Ibiyobyabwenge Byemewe kuri Lymphoma ya Hodgkin

Kumakuru rusange ya kanseri nibindi bikoresho biva mu kigo cyigihugu cya kanseri, reba ibi bikurikira:

• Ibyerekeye Kanseri

• Gutegura

• Chimiotherapie nawe: Inkunga kubantu barwaye Kanseri

• Ubuvuzi bwimirasire nawe: Inkunga kubantu barwaye Kanseri

• Guhangana na Kanseri

• Ibibazo byo Kubaza Muganga wawe kuri Kanseri

• Abacitse ku icumu n'abarezi

Ibyerekeye Iyi ncamake ya

Ibyerekeye

Ikibazo cya Muganga () ni Ikigo cy’igihugu gishinzwe kanseri (NCI) amakuru yuzuye ya kanseri. Ububiko bwa bukubiyemo incamake yamakuru aheruka gutangazwa kubyerekeye kwirinda kanseri, gutahura, genetiki, kuvura, ubuvuzi bufasha, hamwe nubuvuzi bwuzuzanya nubundi buryo. Incamake nyinshi ziza muburyo bubiri. Impuguke zubuzima zubuzima zifite amakuru arambuye yanditse mururimi rwa tekiniki. Impapuro z'abarwayi zanditswe mu buryo bworoshye kubyumva, imvugo idasanzwe. Izi verisiyo zombi zifite amakuru ya kanseri yukuri kandi agezweho kandi verisiyo nyinshi ziraboneka no mu cyesipanyoli.

ni serivisi ya NCI. NCI iri mu bigo by'igihugu byubuzima (NIH). NIH ni ikigo cya leta nkuru yubushakashatsi bwibinyabuzima. Inshamake ya ishingiye ku isuzuma ryigenga ryibitabo byubuvuzi. Ntabwo ari politiki ya NCI cyangwa NIH.

Intego y'iyi ncamake

Iyi ncamake yamakuru ya kanseri ya ifite amakuru agezweho yerekeye kuvura lymphoma ikuze ya Hodgkin. Igamije kumenyesha no gufasha abarwayi, imiryango, n'abarezi. Ntabwo itanga umurongo ngenderwaho cyangwa ibyifuzo byo gufata ibyemezo bijyanye n'ubuvuzi.

Isubiramo namakuru agezweho

Ubuyobozi bwandika incamake yamakuru ya kanseri ya kandi uyakomeze agezweho. Izi Nama zigizwe ninzobere mu kuvura kanseri n’ubundi buhanga bujyanye na kanseri. Inshamake isubirwamo buri gihe kandi impinduka zikorwa mugihe hari amakuru mashya. Itariki kuri buri ncamake ("Yavuguruwe") ni itariki yimpinduka ziheruka.

Ibisobanuro biri muri iyi ncamake y’abarwayi byakuwe muri verisiyo y’umwuga w’ubuzima, isubirwamo buri gihe kandi ikavugururwa uko bikenewe, n’inama y’ubwanditsi ya .

Amakuru Yikigereranyo

Ikigeragezo kivura ni ubushakashatsi bwo gusubiza ikibazo cya siyansi, nko kumenya niba ubuvuzi bumwe buruta ubundi. Ibigeragezo bishingiye kubushakashatsi bwashize nibyigishijwe muri laboratoire. Buri kigeragezo gisubiza ibibazo bimwe na bimwe bya siyansi kugirango ubone uburyo bushya kandi bwiza bwo gufasha abarwayi ba kanseri. Mugihe cyo kuvura ivuriro, amakuru akusanywa kubyerekeye ingaruka zubuvuzi bushya nuburyo bukora. Niba ikigeragezo kivura cyerekana ko ubuvuzi bushya buruta ubwo bukoreshwa ubu, ubuvuzi bushya bushobora guhinduka "bisanzwe." Abarwayi barashobora kwifuza gutekereza kubijyanye no kwipimisha kwa muganga. Ibigeragezo bimwe na bimwe bivura abarwayi batatangiye kuvurwa.

Ibizamini bya Clinical murashobora kubisanga kumurongo wa NCI. Ukeneye ibisobanuro birenzeho, hamagara Serivisi ishinzwe amakuru ya kanseri (CIS), ikigo cya NCI, kuri 1-800-4-KANSERI (1-800-422-6237).

Uruhushya rwo gukoresha Iyi ncamake

ni ikirango cyanditse. Ibiri mu nyandiko za birashobora gukoreshwa kubuntu nkinyandiko. Ntishobora kumenyekana nkincamake yamakuru ya kanseri ya NCI keretse iyo incamake yose yerekanwe kandi igahora ivugururwa buri gihe. Icyakora, umukoresha yemerewe kwandika interuro nka “Incamake yamakuru ya kanseri ya ya NCI yerekeye kwirinda kanseri y'ibere ivuga ingaruka mu buryo bukurikira:

Inzira nziza yo kuvuga iyi ncamake ya ni:

Images in this summary are used with permission of the author(s), artist, and/or publisher for use in the summaries only. If you want to use an image from a summary and you are not using the whole summary, you must get permission from the owner. It cannot be given by the National Cancer Institute. Information about using the images in this summary, along with many other images related to cancer can be found in Visuals Online. Visuals Online is a collection of more than 3,000 scientific images.

Disclaimer

The information in these summaries should not be used to make decisions about insurance reimbursement. More information on insurance coverage is available on Cancer.gov on the Managing Cancer Care page.

Contact Us

Andi makuru yerekeye kutwandikira cyangwa kwakira ubufasha kurubuga rwa Kanseri.gov urashobora kubisanga kurupapuro rwadufasha. Ibibazo birashobora kandi koherezwa kuri Kanseri.gov ukoresheje E-imeri Yurubuga.